CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Nov. 30, 2012	Nov. 30, 2011
Revenue	$ 49,318	$ 49,318
Operating expenses
Selling, general and administrative	869,858	812,239
Research and development	427,994	556,363
Stock-based compensation	326,329	991,488
Depreciation	0	1,087
Total operating expenses	1,624,181	2,361,177
Loss from operations	(1,574,863)	(2,311,859)
Other income (expense)
Grant revenue	0	303,102
Interest expense	(8,137)	(23,588)
Change in fair value of derivative liability	88,663	(81,073)
Gain on extinguishment of liabilities	133,540	159,552
Gain on disposition of equipment	1,500	0
Interest income	697	1,788
Total other income (expense)	216,263	359,781
Net loss	(1,358,600)	(1,952,078)
Less net loss attributable to the noncontrolling interests	(102,350)	(151,420)
Net loss attributable to MultiCell Technologies, Inc.	$ (1,256,250)	$ (1,800,658)
Basic and Diluted Loss Per Common Share (in dollars per share)	$ (0.0012)	$ (0.0026)
Basic and Diluted Weighted-Average Common Shares Outstanding (in shares)	1,035,175,041	692,921,670